W
William Bestermann
Publications - 6
Citations - 152
William Bestermann is an academic researcher. The author has contributed to research in topics: Metabolic syndrome & Framingham Risk Score. The author has an hindex of 4, co-authored 6 publications receiving 150 citations.
Papers
More filters
Journal ArticleDOI
Addressing the Global Cardiovascular Risk of Hypertension, Dyslipidemia, Diabetes Mellitus, and the Metabolic Syndrome in the Southeastern United States, Part II: Treatment Recommendations for Management of the Global Cardiovascular Risk of Hypertension, Dyslipidemia, Diabetes Mellitus, and the Metabolic Syndrome
William Bestermann,Mark C. Houston,Ralph G. Hawkins,Jan Basile,Brent M. Egan,Daniel T. Lackland,Carlos M. Ferrario,Michael A. Moore,James W. Reed,Philip Rogers,Daniel Wise +10 more
TL;DR: An aggressive global approach to screening and to the management of the metabolic syndrome is recommended to slow the growth of the syndrome throughout the United States.
Journal ArticleDOI
Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.
Mark C. Houston,Ralph G. Hawkins,Jan Basile,William Bestermann,Brent M. Egan,Daniel T. Lackland,Michael A. Moore,Carlos M. Ferrario,James W. Reed,Philip Rogers,Daniel Wise +10 more
TL;DR: The components of the metabolic syndrome are analyzed, its pathophysiology is discussed, and an approach to the quantitative analysis of the risk factors contributing to excess cardiovascular death in the region is recommended.
Journal ArticleDOI
The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension.
Carlos M. Ferrario,Jan Basile,William Bestermann,Edward D. Frohlich,Mark C. Houston,Daniel T. Lackland,Ronald D. Smith,Daniel Wise +7 more
TL;DR: The non-invasive method of impedance cardiography to measure hemodynamic abnormalities in hypertensive patients has emerged as a valuable adjuvant in the decision-making process of selecting antihypertensive agents.
Journal ArticleDOI
A systematic approach to managing hypertension and the metabolic syndrome in primary care
TL;DR: The findings demonstrate that application of an evidence-based management algorithm can facilitate higher rates of cardiovascular risk factor control than are generally reported in primary care practices.
Journal ArticleDOI
COSEHC global vascular risk management quality improvement program: rationale and design
Carlos M. Ferrario,Michael A. Moore,William Bestermann,Chris Colby,A. Exuzides,Debra R. Simmons,Sumeet Panjabi +6 more
TL;DR: The CoseHC-11 risk score is statistically similar to the COSEHC-17 risk score and should be a viable tool for evaluating its ability to predict five-year cardiovascular mortality in the coming years.